Back to Careers
CEO Dr. Hanadie Yousef shares more about our JuvNET Platform as an invited seminar speaker for Stanford’s CS 522: Artificial Intelligence in Healthcare course
Back to Careers
CEO, Dr. Hanadie Yousef, joined the Impact a Billion Summit by Transform VC to share how Juvena is using AI and protein science to advance muscle-regenerating therapeutics that promote strength, independence, and healthy aging
Back to Careers
CEO, Dr. Hanadie Yousef, had a rewarding experience moderating and participating in the panel titled “Rethinking Platform Biotech: How Emerging Innovators Are Structuring the Future of Pharma Collaboration” last week at Fierce Biotech Week
Back to Careers
CEO Dr. Hanadie Yousef delivered a seminar at the Buck Institute as a distinguished guest speaker highlighting Juvena’s pioneering work in regenerative biologics and AI-driven drug discovery
Back to Careers
Juvena Therapeutics presented JUV-161 and JUV-112, at ENDO2025, earning recognition from the Endocrine Society for innovation in metabolic and endocrine health
Back to Careers
Dr. Hanadie Yousef participates in the World Economic Forum’s Innovator Communities Meeting and Global Technology Retreat- and shares her expert insights on 2 panels: “Breaking Barriers: Funding Frontier Tech” and “Innovation to Impact: Commercialization Insights from the Field”
Back to Careers
CEO Dr. Hanadie Yousef discusses how the success of GLP-1/GIP receptor agonists is reshaping the treatment of chronic metabolic diseases and driving the next wave of therapeutics targeting the biology of aging at BIO 2025 in Boston
Back to Careers
CEO Dr. Hanadie Yousef joins a panel of industry leaders at BIO 2025 to explore how emerging therapeutic categories are reshaping dealmaking strategies, investment trends, and positioning in today’s evolving biotech landscape
Back to Careers
Director of Translational Biology and Pharmacology, Priya Handa, PhD, and Senior Director of Discovery and Platform, Thach Mai, showcased our research at the 23rd Biopharma Drug Discovery Nexus Conference in San Francisco
Back to Careers
CEO Dr. Hanadie Yousef shares insights on a panel, “Entrepreneurial Excellence in BioPharma: Lessons from the Frontlines,” at SynBioBeta – The Global Synthetic Biology Conference in San Jose
